What conditions is Cuvitru used to treat?
Cuvitru is used as replacement therapy in people who need lifelong help fighting infections because they don’t make enough antibodies (immunoglobulins). That generally means it’s prescribed for primary immunodeficiency diseases and other antibody-deficiency states.
Is it for adults or children?
Cuvitru is used in both adults and children who have antibody deficiencies and need immunoglobulin replacement to help reduce the risk of infections.
How is Cuvitru taken (and why does that matter for use)?
Cuvitru is given as an infusion under the skin (subcutaneous infusion). Using it at home or in outpatient settings is often part of the reason clinicians choose it for long-term immunoglobulin replacement—patients and caregivers are trained on the infusion procedure.
What outcomes is it meant to improve?
The goal of Cuvitru therapy is to lower how often infections happen and reduce the severity of infections by restoring immune protection through immunoglobulin replacement.
Are there other immunoglobulin options instead?
If a patient can’t use Cuvitru (for example, due to tolerability, access, or insurance issues), clinicians may consider other immunoglobulin products or different routes of administration (such as intravenous immunoglobulin) depending on the patient’s diagnosis and treatment plan.
Sources
No sources were provided with your question. If you share a product label link or prescribing information (or tell me the country/version), I can cite the exact labeled indications and age groups.